Development of novel thrombolytic agents

This publication has 16 references indexed in Scilit:

• Coronary thrombolysis with K1K2PU, a chimeric tissue-type and urokinase-type plasminogen activator
  Coronary Artery Disease, 1993
• A recombinant, chimeric enzyme with a novel mechanism of action leading to greater potency and selectivity than tissue-type plasminogen activator.
  Circulation, 1992
• Sustained reflow in dogs with coronary thrombosis with K2P, a novel mutant of tissue-plasminogen activator
  Journal of the American College of Cardiology, 1992
• Thrombolytic properties of Desmodus rotundus (vampire bat) salivary plasminogen activator in experimental pulmonary embolism in rats
  Blood, 1992
• Vampire bat salivary plasminogen activator promotes rapid and sustained reperfusion without concomitant systemic plasminogen activation in a canine model of arterial thrombosis.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
• Pharmacokinetics of the novel recombinant plasminogen activator BM 06.022 in rats, dogs, and non-human primates
  Fibrinolysis, 1992
• Basic and clinical aspects of fibrinolysis and thrombolysis
  Blood, 1991
• Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators.
  Circulation, 1991
• Effective thrombolysis without marked plasminemia after bolus intravenous administration of vampire bat salivary plasminogen activator in rabbits.
  Circulation, 1991
• Innovative Approaches to Plasminogen Activator Therapy
  Science, 1989